Where is HiFiBiO headquartered?

HiFiBiO is located in Cambridge, MA.

Who invested in HiFiBiO?

HiFiBiO has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for HiFiBiO?

HiFiBiO closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

hifibio.com

HiFiBiO

HiFiBiO is a Massachusetts-based biotherapeutics company that discovers, develops and commercializes antibody drugs for the treatment of cancer and autoimmune diseases.

Business Model:

Revenue: $3.9M

Employees: 51-200

Geographic Data

Address: 237 Putnam Ave.

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

series d

Raised Last:

$75M

Raised Total:

$180M

Social

Twitter

Crunchbase

Metrics

4,006,393Website Global Rank

2,985Website Monthly Traffic

Twitter Followers

Description

HiFiBiO is a Massachusetts-based biotherapeutics company that discovers, develops and commercializes antibody drugs for the treatment of cancer and autoimmune diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
9/2016	Series A	1	-	Nest.Bio Ventures Nest.Bio Ventures
1/2019	Venture Round	1	-	Prox Ventures Prox Ventures
5/2018	Series B	6	$37.5M	LYFE Capital Sequoia Capital China Legend Star Nest.Bio Ventures Proxima Ventures Ltd Viventures LYFE Capital Sequoia Capital China
8/2019	Series C		$0	Delian Capital Hanne Capital IDG Capital Kite Pharma Legend Star LYFE Capital Sequoia Capital China VI Ventures Delian Capital Hanne Capital IDG Capital Kite Pharma Legend Star LYFE Capital Sequoia Capital China VI Ventures
6/2021	Series D		$0	B Capital Group Further Grand Mount Capital Hengxu Capital Hong Kong Science and Technology Parks Corporation (HKSTP) IDG Capital Legend Star Maison Capital Mirae Asset Capital Sequoia Capital China Sherpa Venture Capital Trinity Innovation Fund B Capital Group Further Grand Mount Capital Hengxu Capital Hong Kong Science and Technology Parks Corporation (HKSTP) IDG Capital Legend Star Maison Capital Mirae Asset Capital Sequoia Capital China Sherpa Venture Capital Trinity Innovation Fund
6/2021	Series D	12	$75M	Mirae Asset Financial Group B Capital Group Sherpa Healthcare Partners Maison Capital Grand Mount HKSTP Venture Fund IDG Capital Sequoia Capital Legend Star Capital B Capital Group Further Grand Mount Capital Hengxu Capital Hong Kong Science and Technology Parks Corporation (HKSTP) IDG Capital Legend Star Maison Capital Mirae Asset Capital Sequoia Capital China Sherpa Venture Capital Trinity Innovation Fund
8/2019	Series C	8	$67M	IDG Capital Sequoia Capital China VI Ventures Legend Star Capital LYFE Capital Delian Capital Hanne Capital Kite Delian Capital Hanne Capital IDG Capital Kite Pharma Legend Star LYFE Capital Sequoia Capital China VI Ventures
1/2019	Venture Round	1	-	Prox Ventures Prox Ventures
9/2016	Series A	1	-

Acquisitions

Announced Date	Name	Price
10/2018	H-Immune Therapeutics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details